Introduction: Post-treatment surveillance for potentially curable malignancies

Seminars in Oncology

Volumn 30, Issue 3, 2003, Pages 337-

  Wooldridge, James E ^a   Shahab, Nasir ^b   Doll, Donald C ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER RESEARCH; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FOLLOW UP; HEALTH CARE COST; HEALTH SURVEY; HUMAN; LABORATORY TEST; MEDICAL CARE; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION;

EID: 0037792857     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00093-9     Document Type: Editorial

References (0)